Aeglea Biotherapeutics shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $851k | 17k | 50.44 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management